Authors: Martha Powell, Future Science Group
In line with World Immunization Week, we at Infectious Diseases Hub spoke to John-Arne Røttingen about his role in the Coalition for Epidemic Preparedness Innovations (CEPI) – an initiative aiming to prevent future epidemics by promoting the development of new vaccines.
Røttingen has until recently been the founding Chief Executive Officer for CEPI and is now also the Chief Executive of the Research Council of Norway, having held numerous positions in health policy across his career. In this interview he shares his thoughts on the current issues impacting our ability to respond to epidemics, the importance of developing new vaccines, CEPI’s role in epidemic preparedness and more – read the full interview below.
Restricted Content / Members Only
Professor John-Arne Røttingen MD PhD MSc MPA is the Chief Executive of the Research Council of Norway and Adjunct Professor at the Department of Global Health and Population, Harvard T.H. Chan School of Public Health. He was until recently the founding interim Chief Executive Officer of CEPI – Coalition for Epidemic Preparedness Innovations; Executive Director of Infection Control and Environmental Health at the Norwegian Institute of Public Health; and Professor of Health Policy at the Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo. He received his MD and PhD from the University of Oslo, an MSc from Oxford University and an MPA from Harvard University.